UBS Group’s Counterpath Corp CPAH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-366
| Closed | -$1K | – | 9963 |
|
|
2020
Q4 | $1K | Buy |
+366
| New | +$1.1K | ﹤0.01% | 8338 |
|
|
2020
Q3 | – | Sell |
-1,643
| Closed | -$8K | – | 8850 |
|
|
2020
Q2 | $8K | Buy |
1,643
+338
| +26% | +$1.07K | ﹤0.01% | 7193 |
|
|
2020
Q1 | $3K | Buy |
+1,305
| New | +$2.94K | ﹤0.01% | 7583 |
|
|
2019
Q4 | – | Sell |
-3,696
| Closed | -$4K | – | 8809 |
|
|
2019
Q3 | $4K | Buy |
3,696
+200
| +6% | +$265 | ﹤0.01% | 7602 |
|
|
2019
Q2 | $5K | Buy |
3,496
+821
| +31% | +$1.36K | ﹤0.01% | 7426 |
|
|
2019
Q1 | $4K | Sell |
2,675
-4,216
| -61% | -$6.67K | ﹤0.01% | 7310 |
|
|
2018
Q4 | $8K | Buy |
6,891
+4,990
| +262% | +$9.57K | ﹤0.01% | 7389 |
|
|
2018
Q3 | $4K | Buy |
+1,901
| New | +$4.34K | ﹤0.01% | 7627 |
|
|
2018
Q2 | – | Sell |
-1,359
| Closed | -$4K | – | 8629 |
|
|
2018
Q1 | $4K | Buy |
1,359
+896
| +194% | +$3.51K | ﹤0.01% | 7386 |
|
|
2017
Q4 | $1K | Sell |
463
-1,691
| -79% | -$4.36K | ﹤0.01% | 7797 |
|
|
2017
Q3 | $5K | Buy |
2,154
+259
| +14% | +$671 | ﹤0.01% | 7277 |
|
|
2017
Q2 | $4K | Buy |
+1,895
| New | +$3.96K | ﹤0.01% | 7260 |
|
|
2016
Q1 | – | Sell |
-6,230
| Closed | -$16K | – | 8810 |
|
|
2015
Q4 | $16K | Buy |
6,230
+5,854
| +1,557% | +$19.7K | ﹤0.01% | 6983 |
|
|
2015
Q3 | $2K | Buy |
376
+214
| +132% | +$1K | ﹤0.01% | 8159 |
|
|
2015
Q2 | $1K | Buy |
+162
| New | +$888 | ﹤0.01% | 8400 |
|
|
2015
Q1 | – | Sell |
-143
| Closed | -$1K | – | 9956 |
|
|
2014
Q4 | $1K | Buy |
+143
| New | +$1.2K | ﹤0.01% | 9617 |
|
UBS Group's CPAH Position: Q1 2021 in Review
UBS Group sold out of Counterpath Corp (CPAH) in Q1 2021, closing a stake of 366 shares — an estimated $1K sold.
UBS Group first reported a position in CPAH in Q4 2014 and held it in 16 quarters. The position peaked at $16K in Q4 2015. 0 funds tracked by Wall St. Rank hold CPAH as of Q1 2021.
- UBS Group reported no remaining Counterpath Corp position as of Q1 2021 after selling out during the quarter.
- UBS Group sold 366 Counterpath Corp shares in Q1 2021, an estimated $1K.
- UBS Group first reported a position in Counterpath Corp in Q4 2014 and held it in 16 quarters.
- UBS Group's Counterpath Corp position peaked at $16K in Q4 2015.
- 0 funds tracked by Wall St. Rank held Counterpath Corp as of Q1 2021.
Based on UBS Group's 13F filing for Q1 2021, filed 12 May 2021.